Catalyst Wire Dossier Catalyst Wire Dossier

VOXZOGO 0.4MG

vosoritide · BioMarin Pharmaceutical Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VOXZOGO 0.4MG, covering 2023-10-20 to 2023-10-20. Get the full timeline:

Most recent: FDA Approved: VOXZOGO 0.4MG — Supplemental Application (BioMarin Pharmaceutical Inc.)

See pricing